The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry
Crossref DOI link: https://doi.org/10.1186/s13063-015-1100-8
Published Online: 2015-12-19
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bramlage, Peter
,
Schmieder, Roland E.
Gitt, Anselm K.
Baumgart, Peter
Mahfoud, Felix
Buhck, Hartmut
Ouarrak, Taoufik
Ehmen, Martina
Potthoff, Sebastian A.
License valid from 2015-12-01